Selected Publications

Gibson NM, Khandros E, Elgarten CW, Worster E, Monos DS, Thompson AA, Kwiatkowski JL, Olson T.: Impact of HLA Alloimmunization in Gene-Modified Autologous Stem Cell Transplant For Transfusion-Dependent Thalassemia. Blood Mar 2025.

Vasileiadi E, Elgarten CW, Fisher BT: Comparative outcomes of pediatric patients with hematologic malignancies with fluoroquinolone gram negative bacteremia vs fluoroquinolone susceptible gram negative bacteremia. St. Jude/PIDS Pediatric Infectious Diseases Conference Mar 2025.

Morrison K, Blumenstock JA, Fisher BT, Elgarten CW: Exploring the Gut Microbiome and its Potential Association with Bacteremia in Pediatric Hematopoietic Cell Transplant Patients. St. Jude/PIDS Pediatric Infectious Diseases Conference March 2025.

Slatnick LR, Hoogstra D, Fisher BT, Wolf J, Orgel E, Nessle CN, Patel PA, Miller TP, Wilkes J, Dupuis LL, Goode E, Jackson K, Willis DN, Elgarten C, Aftandilian C, Thompson J, Alexander S, Beauchemin MP, Belsky JA, Hess J, Prudowsky ZD, Guinipero T, Rossoff J, Demedis J, Walsh AM, Richards R, Choi DK, Dvorak CC, Esbenshade AJ: Prevention and Management of Infectious Complications in Pediatric Patients with Cancer: A Survey Assessment of Current Practices Across Children’s Oncology Group Institutions. Pediatric Blood & Cancer 72(23), Mar 2025.

Martin L, Carlesse F, Elgarten CW, Groll AH, Koenig C, Kourti M, Morgan JE, Pana ZD, Petrikkos L, Phillips B, Tragiannidis A, Vasileiadi E, Ammann RA, Brack E, Dupuis LL, Ebrahimi-Fakhari D, Mesini A, Solopova G, Sung L, Vissing N, Lehrnbecher T.: Addressing infectious challenges in pediatric cancer and hematopoietic cell transplantation: insights from the Umbrella Working Group. Support Care Cancer 33: 264, Mar 2025.

Elgarten CW, Wilson N, Thornton CP, Blumenstock JA, Morrison K, Fisher BF: Oral microbiome features correlate with mucositis in pediatric patients receiving chemotherapy. St. Jude/PIDS Pediatric Infectious Diseases Conference Mar 2025 Notes: Awarded Best Abstract.

Phillips R, Fisher BT, Ladas EJ, Patel P, Robinson PD, Dupuis LL, Ammann RA, Beauchemin MP, Carlesse F, Castagnola E, Davis BL, Efremov K, Elgarten CW, Groll AH, Haeusler GM, Koenig C, Morris A, Santolaya ME, Spinelli D, Tissing WJE, Wolf J, Sung L, Lehrnbecher T.: Use of food restrictions to prevent infections in paediatric patients with cancer and haematopoietic cell transplantation recipients: a systematic review and clinical practice guideline. EClinicalMedicine 81: 103093, Feb 2025.

Gibson NM, Friedman DF, Elgarten CW, Haimed A, Thompson AA, Khandros E, Wray L, Wang Yongping, Kwiatkowski JL, Olson TS: Post-approval, Real-World Experience with Betibeglogene Autotemcel for Transfusion-Dependent Beta Thalassemia. TCT Feb 2025.

Maron GM, Boeckh MJ, Papanicolaou GA, Gomez CA, Prasad VK, Dara J, Elgarten CW, Kumar M, Wynn RF, Fukushima K, Maher R, Azie N, Grimley M: Adenoviremia Clearance Following Treatment with Intravenous (IV) Brincidofovir (BCV) in Immunocompromised Patients is Associated with Positive Clinical Disease Response: Preliminary Outcomes from the ATHENA Phase IIa Study. IDWeek Jan 2025.

Zheng DJ, Hettinger G, Elgarten CW, Fisher BT, Gathers C, Huang YSV, Ko J, Leger K, Li Y, Myers R, Narayan HK, Ortiz J, Seif AE, Aplenc R, Getz KD: Near Universal National Uptake of Dexrazoxane in the Real-World Setting Associated with Reduced Cardiac ICU Care Requirements in Pediatric Acute Myeloid Leukemia ASH Dec 2024.